Citation: M. Higuchi et al., The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines, J VIROLOGY, 76(1), 2002, pp. 455-459
Citation: M. Higuchi et al., Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptorcytoplasmic factors, P NAS US, 98(8), 2001, pp. 4675-4680
Citation: Edc. Mcfarland et al., Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappa B, ONCOGENE, 18(49), 1999, pp. 6959-6964
Authors:
Izumi, KM
McFarland, EC
Ting, AT
Riley, EA
Seed, B
Kieff, ED
Citation: Km. Izumi et al., The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappa B activation, MOL CELL B, 19(8), 1999, pp. 5759-5767
Authors:
Izumi, KM
McFarland, EC
Riley, EA
Rizzo, D
Chen, YZ
Kieff, E
Citation: Km. Izumi et al., The residues between the two transformation effector sites of Epstein-Barrvirus latent membrane protein 1 are not critical for B-lymphocyte growth transformation, J VIROLOGY, 73(12), 1999, pp. 9908-9916
Authors:
Kaye, KM
Izumi, KM
Li, H
Johannsen, E
Davidson, D
Longnecker, R
Kieff, E
Citation: Km. Kaye et al., An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation, J VIROLOGY, 73(12), 1999, pp. 10525-10530